The research in the Cravatt laboratory has focused on the functional characterization of enzymatic pathways in mammalian biology using integrated chemical and systems biology approaches. His group has advanced the chemical proteomic method activity-based protein profiling (ABPP) that uses active site-directed small-molecule probes to broadly profile the functional state of enzymes in native biological systems. They have applied ABPP in combination with metabolomics methods to determine the function of uncharacterized enzymes in human cancer, as well as to map enzymes that regulate endogenous signaling lipids in the nervous system. Chief among the latter class of enzymes is fatty acid amide hydrolase (FAAH), which the Cravatt lab has shown serves as a principal regulator of endocannabinoid signaling in vivo.
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